ImmunityBio, Inc. — Director's Dealing 2017

Sep 20, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2017-09-18

Reporting Person: DRISCOLL FREDERICK W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-18	Common Stock	A	54621	$0.00	Acquired	54621	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of NantKwest, Inc. common stock. Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, one thirty-sixth (1/36th) of the RSUs subject to the award will vest monthly over thirty six (36) months, such that the award will be fully vested on September 18, 2020.